Medicare Enrolled

Dr. Angelina The, MD

Hematology & Oncology · Delray Beach, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
6282 LINTON BLVD, Delray Beach, FL 33484
5619556400
In practice since 2006 (19 years)
NPI: 1417976457 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. The from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. The? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. The

Dr. Angelina The is a hematology & oncology in Delray Beach, FL, with 19 years in practice. Based on federal Medicare data, Dr. The performed 1,424 Medicare services across 852 unique beneficiaries.

Between the years covered by Open Payments, Dr. The received a total of $10,025 from 59 pharmaceutical and/or device companies across 525 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. The is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 35% volume in FL$ $10,025 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,424
Medicare services
Top 35% in FL for hematology & oncology
852
Unique beneficiaries
$86
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~75 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)833$77$263
Hospital follow-up visit, moderate complexity246$66$164
Initial hospital admission, high complexity106$141$359
Office visit, established patient, complex (40-54 min)73$116$369
New patient office visit, complex (60-74 min)67$150$456
New patient office visit (45-59 min)47$110$346
Office visit, established patient (20-29 min)32$55$187
Initial hospital admission, moderate complexity20$106$272
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$10,025
Total received (2018-2024)
Avg $1,432/year across 7 years
Top 36% in FL for hematology & oncology
59
Companies
525
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,474 (84.5%)
Other
Charitable contributions, space rental, and other categories
$1,495 (14.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$56 (0.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,628
2023
$1,441
2022
$500
2021
$219
2020
$430
2019
$2,622
2018
$2,186

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,692
AstraZeneca Pharmaceuticals LP
$827
PFIZER INC.
$738
Lilly USA, LLC
$489
GENZYME CORPORATION
$486
Merck Sharp & Dohme Corporation
$396
E.R. Squibb & Sons, L.L.C.
$371
Celgene Corporation
$346
Janssen Biotech, Inc.
$343
Genentech USA, Inc.
$342
NOVARTIS PHARMACEUTICALS CORPORATION
$318
Takeda Pharmaceuticals U.S.A., Inc.
$303
Incyte Corporation
$242
Merck Sharp & Dohme LLC
$205
Puma Biotechnology, Inc.
$200
Ipsen Biopharmaceuticals, Inc
$169
SOBI, INC
$157
Alexion Pharmaceuticals, Inc.
$154
Boehringer Ingelheim Pharmaceuticals, Inc.
$145
AbbVie, Inc.
$135
Seagen Inc.
$116
BeiGene USA, Inc.
$110
Amgen Inc.
$108
TerSera Therapeutics LLC
$89
Dova Pharmaceuticals
$87
Astellas Pharma US Inc
$82
Bayer HealthCare Pharmaceuticals Inc.
$77
Gilead Sciences, Inc.
$74
Pharmacyclics LLC, An AbbVie Company
$74
AbbVie Inc.
$73
Eisai Inc.
$72
ABBVIE INC.
$71
Agios Pharmaceuticals, Inc.
$64
Spectrum Pharmaceuticals Inc.
$63
GlaxoSmithKline, LLC.
$63
Daiichi Sankyo Inc.
$60
Aurobindo Pharma USA, Inc.
$54
Kite Pharma, Inc.
$51
INSYS Therapeutics Inc
$51
Deciphera Pharmaceuticals Inc.
$45
AMAG Pharmaceuticals, Inc.
$44
Karyopharm Therapeutics Inc.
$40
MEDIVATION FIELD SOLUTIONS LLC
$40
Taiho Oncology, Inc.
$39
Aveo Pharmaceuticals, Inc.
$35
Adaptive Biotechnologies Corporation
$29
Genentech, Inc.
$26
Rigel Pharmaceuticals, Inc.
$26
Bayer Healthcare Pharmaceuticals Inc.
$25
Alnylam Pharmaceuticals Inc.
$24
ARRAY BIOPHARMA INC
$22
Exelixis Inc.
$19
SANOFI-AVENTIS U.S. LLC
$19
TESARO, Inc.
$18
RECORDATI_RARE_DISEASES_INC.
$18
Clovis Oncology, Inc.
$17
EISAI INC.
$16
PUMA BIOTECHNOLOGY, INC.
$15
Kyowa Kirin, Inc.
$13
Top 3 companies account for 32.5% of total payments
Associated products mentioned in payments ›
AFINITOR · ALIMTA · ALUNBRIG · Alecensa · BOSULIF · BRUKINSA · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CERDELGA · CEREZYME · CHANTIX · CYRAMZA · DARZALEX · Doptelet · ELAHERE · ELIQUIS · ELITEK · EMEND · EMPLICITI · ENHERTU · ENJAYMO · ERLEADA · Enhertu · Erleada · FERAHEME · FOTIVDA · FRUZAQLA · Folotyn · GAUCHER-DISEASE · GILOTRIF · GIVLAARI · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INLYTA · Imbruvica · JADENU · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LORBRENA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OJJAARA · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · PADCEV · PIQRAY · PLUVICTO · PROMACTA · Padcev · Phesgo · Polivy · Pomalyst · QINLOCK · REBLOZYL · Revlimid · Rubraca · SANCUSO · SARCLISA · SOLIRIS · SOMATULINE DEPOT · SUBSYS · SUTENT · SYLVANT · SYNDROS · Somatuline Depot · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tazverik · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VPRIV · Venclexta · XALKORI · XPOVIO · XTANDI · Yescarta · ZEJULA · ZOLADEX · ZYTIGA · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (84%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $704 per 100 Medicare services performed
Looking for a hematology & oncology in Delray Beach?
Compare hematology & oncologys in the Delray Beach area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncologys nearby

Geographic Context

Hematology & Oncologys within 10 mi
62
Per 100K population
4.1
County median income
$81,115
Nearest hospital
DELRAY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. The is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. The experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. The performed 833 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. The receive payments from pharmaceutical companies?
Yes. Dr. The received a total of $10,025 from 59 companies across 525 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. The's costs compare to other hematology & oncologys in Delray Beach?
Dr. The's average Medicare payment per service is $86. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. The) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →